252 related articles for article (PubMed ID: 29749537)
1. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
Kumata Y; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Soeda N; Kiyokawa T; Horikawa M; Fukushima R
Oncol Rep; 2018 Jul; 40(1):319-330. PubMed ID: 29749537
[TBL] [Abstract][Full Text] [Related]
2. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
6. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.
Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R
Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
Liu X; Chu KM
J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
[TBL] [Abstract][Full Text] [Related]
8. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.
Dejima H; Iinuma H; Kanaoka R; Matsutani N; Kawamura M
Oncol Lett; 2017 Mar; 13(3):1256-1263. PubMed ID: 28454243
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
10. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer.
Zhao R; Zhang Y; Zhang X; Yang Y; Zheng X; Li X; Liu Y; Zhang Y
Mol Cancer; 2018 Feb; 17(1):68. PubMed ID: 29486794
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
Hou CG; Luo XY; Li G
Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
14. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY
Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888
[TBL] [Abstract][Full Text] [Related]
15. Decreased Serum Exosomal microRNA-134 Expression and Its Prognostic Value in Gastric Cancer.
Jin Z; Song Y; Lian C; Gao L
Ann Clin Lab Sci; 2022 Jul; 52(4):563-570. PubMed ID: 36197781
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
18. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer.
Yang H; Fu H; Wang B; Zhang X; Mao J; Li X; Wang M; Sun Z; Qian H; Xu W
Mol Carcinog; 2018 Sep; 57(9):1223-1236. PubMed ID: 29749061
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
